Next Article in Journal
RETRACTED: Bi and Sn Doping Improved the Structural, Optical and Photovoltaic Properties of MAPbI3-Based Perovskite Solar Cells
Previous Article in Journal
Comment on Kierlik et al. Application of Mössbauer Spectroscopy for Identification of Iron-Containing Components in Upper Silesian Topsoil Being under Industrial Anthropopressure. Materials 2020, 13, 5206
Previous Article in Special Issue
Characterization of Biological Properties of Dental Pulp Stem Cells Grown on an Electrospun Poly(l-lactide-co-caprolactone) Scaffold
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Medical Adhesives and Their Role in Laparoscopic Surgery—A Review of Literature

1
Department of Surgery, 4th Military Teaching Hospital in Wroclaw, Weigla 5, 50-981 Wroclaw, Poland
2
Pre-Clinical Research Centre, Wroclaw Medical University, Bujwida 44, 50-345 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Materials 2022, 15(15), 5215; https://doi.org/10.3390/ma15155215
Submission received: 27 April 2022 / Revised: 15 June 2022 / Accepted: 20 July 2022 / Published: 28 July 2022

Abstract

:
Laparoscopic surgery is undergoing rapid development. Replacing the traditional method of joining cut tissues with sutures or staples could greatly simplify and speed up laparoscopic procedures. This alternative could undoubtedly be adhesives. For decades, scientists have been working on a material to bond tissues together to create the best possible conditions for tissue regeneration. The results of research on tissue adhesives achieved over the past years show comparable treatment effects to traditional methods. Tissue adhesives are a good alternative to surgical sutures in wound closure. This article is a review of the most important groups of tissue adhesives including their properties and possible applications. Recent reports on the development of biological adhesives are also discussed.

1. Introduction

Adhesive is a generic term and includes other common terms such as adhesive, paste, gum, and bonding agent [1,2]. Adhesives are defined as nonmetallic substances capable of bonding materials together by joining surfaces. The bond itself has sufficient internal strength (cohesion). Already prehistoric hunters discovered that human or animal blood can adhere hair together and can be used as an adhesive. In ancient China, adhesives of plant origin were used, while the Egyptians used gum arabic, among other things, to thicken cosmetics. A spectacular breakthrough came with the development of the chemical industry in the early 20th century, which led to the discovery of phenolic, urea, epoxy, cyanoacrylate, and many other resins. Adhesives quickly found their way into medical applications [3].
Tissue adhesives are used to create functional connections between damaged tissues and between tissues and implanted biomaterials [4]. Millions of patients worldwide suffer from surgical wounds or incisions that require effective closure, accelerated healing, and tissue regeneration [5]. Surgical sutures and mechanical methods of tissue fusion are useful for conventional open surgery. Sutures and mechanical methods are not without risks of intolerance and toxicity [5,6]. An ideal tissue adhesive should meet the appropriate criteria to be widely used in clinical practice [7,8]:
  • It should be biocompatible and biodegradable
  • The adhesive application should be as simple as possible
  • The adhesive curing process should be relatively short
  • Mechanical strength, cohesion, and adhesion in a humid environment should be appropriate for the specific application
  • The adhesive should not cause an inflammatory reaction with large swelling
  • The adhesive should be durable and stable
  • Production costs must be economically viable
Available tissue adhesives can be divided into natural and synthetic. Synthetic adhesives have strong mechanical properties, low degradation rates, and their degradation products are cytotoxic, which limits their clinical application [9]. Natural adhesives, including fibrin adhesives and collagen-based products, are effective in adhesion; unfortunately, their availability is limited due to autologous tissue isolation. In addition, researchers note the often poor tensile strength of adhesives [10]. When designing an adhesive, the aim is to optimize specific desired parameters while maintaining its overall characteristics [11]. Other important parameters for tissue adhesives are mechanical stability and biocompatible integration with other biomaterials [12,13]. An ideal tissue adhesive should form an interface that connects the biomaterial to the tissue. Ideal adhesives should be able to modulate cellular activity through active biological signals [14,15,16]. Recent research has focused on creating a hybrid system. This would consist of an adhesive that would have features of the cellular microenvironment to mimic the extracellular architecture and biology of a given tissue [12,17,18]. The following chapters of this manuscript focus on adhesives, their division into natural or artificial ones, and the following features of example materials. Additionally, the manuscript focuses on the very promising application of stem cells in regenerative medicine, especially when it comes to adhesives.

2. Natural Adhesives

2.1. Fibrin Adhesives

Fibrin adhesives are made from human or animal plasma, are biodegradable, easy to use, and can be stored at room temperature or in the refrigerator. Fibrin adhesive has strong hemostatic properties. The basic components of the adhesive are fibrinogen and thrombin [19,20]. In the presence of calcium chloride, thrombin breaks fibrinogen chains to form fibrin. After 2 weeks, the clot formed is completely absorbed; therefore, the adhesive does not cause an inflammatory response. Fibrin gels can serve as an autologous biodegradable scaffold. The tensile strength of a fibrin clot depends on the concentration of fibrinogen in the adhesive, which ranges from 40 to 115 mg/mL. The adhesive strength is much lower compared to cyanoacrylate adhesive. Fibrin adhesive has been used since the 1970s to achieve hemostasis in cardiac surgery [21,22] to seal vascular grafts and to treat aortic dissection in vascular surgery [23,24]. Prevention of sudden bleeding during surgery requires the support of fibrin adhesive with sutures, staples, or sponge because the strength of the adhesive is reduced in moist environments [25,26,27,28,29,30]. In neurosurgery, it can be used to close the dura to prevent leakage of cerebrospinal fluid (CSF) and to repair leaks in the dura [31,32,33]. The fibrin adhesive Tissucol has also found use in plastic surgery as a means to provide hemostasis in the treatment of burn wounds [34]. Adhesives can also be used in endoscopic procedures to treat peptic ulcers [35]. Fibrin adhesive can also be used in laparoscopic inguinal hernia repair using the Totally Extraperitoneal Repair (TEP) technique. Researchers compared the results of two groups of patients; in the first group, the polypropylene mesh was attached using staples, while in the second group it was attached using fibrin adhesive. The study showed a lower incidence of hematoma, pain, postoperative neuralgia, and a faster return to work in patients in the second group [36]. Another study conducted on patients treated laparoscopically with transabdominal preperitoneal mesh placement (TAPP—transabdominal preperitoneal repair) found no statistically significant difference in the patient’s postoperative hospital stay, recovery time, recurrence rate, and complications [37]. This allows to conclude that adhesive treatment leads to the same good treatment results as classical methods. One of the studies reports a case of a successful treatment of a large lymphangioma located in the mediastinum by drainage and fibrin adhesive injections [38]. Four-year follow-up showed no recurrence. Adhesive has been used to seal the pleura [39] and even to treat bronchial fistulas [40]. Pneumothorax is one of the complications in premature infants with respiratory failure and is associated with high mortality. In 12 cases of pleurodesis with fibrin adhesive, permanent pleural seal occurred [41]. One of the most common complications after kidney transplantation is lymphocele. The authors evaluated and compared three treatment procedures in these patients: open surgical drainage, laparoscopic drainage, and percutaneous drainage with fibrin adhesive injections. The use of the adhesive resulted in the best outcomes, with a lower recurrence rate of 7.7% compared to laparoscopic drainage at 54% and surgical drainage at 27.3%. In addition, the cost of treatment was lower, and the procedure could be performed on an outpatient basis under local anesthesia [42]. Furthermore, adhesive can be used in otolaryngology after radical lymph node excision to prevent lymphatic leakage [43]. The use of adhesives in knee replacement surgery has helped to reduce bleeding during surgery [44]. Research is ongoing into the use of fibrin adhesives as a carrier for anticancer drugs. Studies have been conducted on mice that were implanted with colon cancer cells into the subcutaneous tissue. The results of oxaliplatin used alone and in combination with fibrin adhesive were compared. Greater tumor apoptosis, decreased proliferation, and inhibition of tumor angiogenesis were observed in the group treated with oxaliplatin with fibrin adhesive [45]. The use of fibrin adhesive in the treatment of nerve injury is ongoing. A study used the sciatic nerve in mice [46]. It showed faster axonal regeneration, and better electrophysiological and functional outcome of the nerve after treatment with adhesive compared to microsurgical suturing. The use of adhesives also reduced the regeneration time of the injured nerve [47]. The main advantages of using fibrin-based adhesives are lack of toxicity, biocompatibility, and the natural degradation process. Fibrin-based adhesive can also be applied as foam [48]. It is worth noting that animal studies have proven the superiority of foam over the liquid form of the adhesive when in contact with blood [49]. Hybrid materials such as TachoComb [50], which is used in Europe and consists of a thin layer of lyophilized human fibrinogen and bovine thrombin placed on one side of a sheet of horse collagen, have proven their effectiveness in controlling bleeding [51,52]. The weaknesses of fibrin products include the method of manufacture, while the autologous isolation from tissue limits the availability of fibrin and makes fibrin adhesives relatively expensive. There are also some concerns about the safety of using thrombin from bovine sources, including allergic reactions and the transmission of infection. Horowitz and Busch [53] studied the safety of fibrin adhesives. In their study, the authors reported a risk of parvovirus transmission of approximately 1/500,000 vials of fibrinogen, whereas the risk of HIV, HCV, HBV, and HAV infection was 1 in 10 to the power of 15. The potential risk of Creutzfeldt–Jacob disease infection cannot be excluded either [54,55]. In addition, the adhesive shows low adhesion strength due to the poor cohesive properties, and may be difficult to apply because the polymerization time is difficult to control during application [56]. Bjork et al. [57] developed a new crosslinking method based on ruthenium and blue visible light that results in a three-fold increase in the mechanical strength and a ten-fold increase in the stiffness by adjusting the exposure time and culture duration on both fibrin- and collagen-based constructs.

2.2. Collagen Adhesives

Another group of natural adhesives are collagen-based adhesives. Collagen has adsorption properties of coagulation products that cause the adhesive to adhere to the wound by inducing platelet adhesion and activating clotting factors [58,59]. In the US, an adhesive called FloSeal [60] was registered to produce hemostasis in vascular surgery, while the Proceed product is designed to prevent and treat cerebrospinal fluid leaks [61]. Another novel collagen product is Costasis [62], which is a combination of autologous human plasma and a mixture of bovine collagen and thrombin. It has been used as a spray for surgical hemostasis and in endoscopic gastrointestinal bleeding [63]. However, researchers point out that, as with any zoonotic adhesive, there is a risk of transmission of infection and allergic reaction.

2.3. Gelatin-Based Adhesives

Gelatin adhesives have attracted the attention of researchers because of their many applications in soft tissue bonding. In addition, they can be used to prevent and treat both liquid and gaseous leaks [64]. Gelatin itself is a widely used collagen derivative which is obtained with use of a controlled process of hydrolysis, and is a major part of the skin, connective tissue, and skeletal system [65,66]. Adhesives based on this material are inexpensive to produce and their ingredients are widely available. Potential complications after adhesive use include vasoconstriction at the site of administration or movement of the adhesive substance from the site of administration to a distant site. Elvin et al. [67] demonstrated that photochemically crosslinked gelatin-based adhesive demonstrates a high adhesive strength (>100 kPa), a high elasticity (>600% elongation to break), and a high tensile strength (approximately 2.0 MPa). Some in vitro studies [68,69,70] have shown that calcium-independent microbial transglutaminase (mTG) can crosslink gelatin to form a gel within minutes. The mTG gelatin adhesive can bond to moist and wet tissues, and the adhesive strength is comparable or even better than the fibrin-based adhesive. Its surgical potential has been evaluated highly in in vivo studies using rats and pigs [71]. A gelatin–resorcinol adhesive crosslinked with formaldehyde (GRF) or glutaraldehyde (GRFG) is an interesting solution. The adhesive itself consists of the organic components resorcinol, gelatin, and water [72]. The curing process of the adhesive occurs in the presence of formaldehyde, glutaraldehyde, or under the influence of high temperature [73]. The cured bond is formed by heating a mixture in the ratio of three parts gelatin to one part resorcinol. Crosslinking occurs after approximately 30 s. Currently, there is one adhesive, BioGlue (CryoLife, Inc., 1655 Roberts Blvd NW, Kennesaw, GA 30144, USA) based on GRF that has been approved in the US by the FDA [74]. In BioGlue, the formaldehyde component was omitted due to its toxic potential. To date, no other GRF adhesive has been approved by the US FDA because the long-term results are not yet known. This adhesive has been used worldwide in a wide variety of surgical procedures including: cardiac surgery (aortic valve replacement, coronary artery bypass grafting, aortic dissection repair, and abdominal aortic aneurysm repair), as well as vascular, pulmonary, gastrointestinal, and general surgical procedures [75]. The adhesive has neutral properties and is an excellent agent in stopping bleeding from vessels and from moist surfaces of bleeding parenchymal organs. Therefore, it can be used by all fields of medicine to maintain hemostasis. Researchers are also creating hybrid products such as FloSeal consisting of crosslinked gelatin and thrombin. As with cyanoacrylate adhesives, GRF adhesives are considered potentially cytotoxic and are poorly resorbable. Other GRFG adhesives are still under investigation for their potential use in thoracic and vascular surgery [76].

2.4. Chitosan-Based Adhesives

Chitosan is a polysaccharide commercially produced by the deacetylation of chitin, which is a structural element present in the exoskeleton of crustaceans (e.g., crabs and shrimp) and in the cell walls of fungi. The hemostatic properties of chitosan are well known. The patented product Hem Con [77] demonstrated that the adhesives are able to control severe organ bleeding and large venous hemorrhage induced on a pig animal model [78]. The efficacy of the indicated product has been demonstrated for military [79] and civilian use [80]. Powder-based chitosan adhesives have also been developed. One example is Celox, which is a patented formulation in the form of granules prepared from more than one type of chitosan [81,82]. Its efficiency as a hemostatic product was confirmed by Kozen et al. [82] and Kheirabadi et al. [83]. Klokkevolt et al. [84] demonstrated that chitosan effectively reduces oral bleeding from tongue wounds. Lauto et al. [85,86] used a chitosan-based adhesive in vivo in nerve anastomosis in the repair of an injured intestine with good clinical results. This tissue adhesive may be suitable for skin wound closure and in situations requiring urgent hemostasis [87,88]. Chitosan-based adhesives can also effectively close scleral wounds [89]. Hoekstra et al. [90] demonstrated that the use of microcrystalline chitosan (MCCh) as a vascular sheath after arterial catheterization helps restore hemostasis.

2.5. Chondroitin Sulfate-Based Adhesives

Chondroitin sulfate is a glycosaminoglycan composed of a chain of sugars (N-acetylgalactosamine and glucuronic acid). The chondroitin chain can contain 100 individual sugars, each of which can be sulfated in different positions and sizes. Chondroitin sulfate is an important structural element of cartilage and provides high resistance to compression [91,92]. Wang et al. [93] described the use of a chondroitin-based adhesive to bind both the patient’s own cartilage tissue and the implanted biomaterial. The developed adhesive integrates the implant with the surrounding own tissues, which is essential for the immediate and long-term recovery of organ function. In vitro and in vivo studies confirmed that the adhesive stimulated extracellular matrix production and tissue regeneration. The adhesive may also be helpful and an alternative to sutures used in ophthalmology during keratoplasty surgery [94].

3. Synthetic Adhesives

3.1. Cyanoacrylate Adhesives

The history of cyanoacrylates dates back to the 1950s. The bonding properties of cyanoacrylate adhesive were discovered by accident by Eastman Codack Company scientists while working on fairings for jet aircraft. In 1951, while making refractive index measurements, samples of ethyl 2-cyanoacrylate got stuck in the prisms of a refractometer. A few years later, in 1958, the glue first went on sale commercially as Super Glue [95,96,97,98,99,100].
Cyanoacrylate glue was quickly found to exhibit excellent adhesion to a wide variety of materials, including plastics, rubber, metals, ceramics, wood, glass, paper, fabrics, cement, and tissues. [101,102,103]. The monomer cyanoacrylate polymerizes very rapidly in the presence of weak bases without heat or catalyst at room temperature. The rate of polymerization of liquid cyanoacrylate monomer in the presence of weak bases makes it a very fast drying adhesive and cures quickly [104,105,106,107,108]. The chemical structure of cyanoacrylate monomers can be generally characterized as an acrylate backbone with two electronegative groups. The electron-withdrawing groups can undergo anionic polymerization in the presence of bases to produce a glass-like polymer [109,110,111]. Cyanoacrylate adhesives are ideal for medical and dental applications, especially as tissue bonding adhesives and sealing materials.
In dentistry, medicine, and veterinary medicine, agents based on butyl cyanoacrylate, heptyl cyanoacrylate, octyl cyanoacrylate, and ethoxyethyl cyanoacrylate have been used and are distinguished by [102,103,112,113]:
-
Hydrophilicity, good spreading in living tissue;
-
Lower heat generation during polymerization, which helps avoid tissue necrosis;
-
Better mechanical properties (especially elasticity and cosmetic results);
-
Lesser toxicity—their degradation products can be metabolized and removed from the body.
In the United States, the Food and Drug Administration (FDA) has so far approved only two cyanoacrylate compounds (n-butyl 2-cyanoacrylate and 2-octyl cyanoacrylate), most of which are for external clinical use. In other countries, these adhesives have been approved for internal use. An analysis of 10 years of experience in treating esophageal and gastric variceal bleeding with endoscopic cyanoacrylate adhesive by American scholars from the University of Iowa demonstrated the efficacy in achieving hemostasis in 96% of the treated acute bleeding cases [104]. A study was conducted to evaluate the efficacy and safety of transcatheter embolization with cyanoacrylate adhesive of acute arterial hemorrhages of various etiologies. Analysis of bleeding outcomes showed a 76% therapeutic success rate in patients treated with cyanoacrylate adhesive [105]. The adhesive can also be successfully used for mesh fixation during conventional inguinal hernia repair. Egyptian researchers observed fewer local complications in a study group using cyanoacrylate adhesive and sutures compared to a control group in which the mesh was fixed only with surgical sutures [106]. In dentistry, cyanoacrylate adhesive has been shown to play a beneficial role in promoting soft and hard tissue healing in postextraction wounds during the dental implant placement procedure [107]. Researchers, in comparing the effectiveness of treating dentinal hypersensitivity with laser and cyanoacrylate adhesive, came to some interesting results [108]. In a study conducted on 62 patients with a total of 432 teeth treated, a faster hypersensitivity reduction effect was demonstrated with the adhesive within the first 24 h of treatment. Cyanoacrylate adhesive may be an alternative to sutures after the surgical removal of the third molars. Researchers studied 60 patients who had two molars removed on opposite sides. They found less pain, bleeding, swelling, and sensitivity on the side where cyanoacrylate adhesive was used. Moreover, the number of successfully treated was higher in the adhesive group, 52 vs. 39 [114]. The use of adhesives for skin wound closure has been well described in the literature [10,111,112,113,115,116,117]. One commercially available adhesive is Dermabond. This adhesive is widely used for the closure of small and superficial skin wounds [118]. One disadvantage of cyanoacrylate adhesives is their high price compared to surgical sutures. Glubran2 is a cyanoacrylate adhesive that is approved for use in the European Union in classical and laparoscopic surgery as well as in endoscopy and interventional radiology [119]. It is applied to the skin, provides a good cosmetic result, and eliminates the need for suture removal. A study by Kull et al. [10] showed the better tensile strength of the Glubran2 adhesive on biological substrates compared to a fibrin adhesive. More recent studies also support this. Experts evaluating the appearance of wounds after skin cancer surgery found no statistically significant differences in the aesthetics in wounds closed with cyanoacrylate adhesive compared to surgical sutures [120,121]. The advantages of adhesives are also recognized by plastic surgeons, emergency physicians, and pediatric surgeons who want to protect a child from the trauma of surgical suturing [122]. Adhesives can also be used to treat lower extremity venous insufficiency. A study of 29 patients showed the successful closure of 56 of 57 saphenous veins [123]. There were no complications of deep vein thrombosis or recurrence during the 9-month follow-up period. Dragu et al. [124] demonstrated that a foreign body reaction can occur after the use of an adhesive to treat a superficial wound. While using the adhesive, the risk of wound infection is small and, according to several studies, its values reached the maximum of 8%. [125,126,127].
Adhesives need to be used with the appropriate personal protective equipment in a room with adequate ventilation because cyanoacrylate is a strong adhesive (rapid exothermic polymerization) and exposure to large quantities causes irritation to the eyes, nose, and throat [128]. Additionally, adhesives should only be used away from open flames, sparks, and high temperatures, because both the polymer cyanoacrylate and its monomer sustain combustion [102,129,130].
In the future, the use of cyanoacrylates in medicine will increase as their toxicity decreases and their shelf life is extended for use in external and internal tissues. The second area will be the construction of cyanoacrylate adhesives in the form of nanofibers.

3.2. PEG Polyethylene Glycol-Based Adhesives

This group of tissue adhesives consists of linear or branched polyethylene glycol(PEG) molecules that can be crosslinked chemically or under ultraviolet light, depending on the available chemical groups. Photocrosslinking of PEG-based adhesives occurs in the presence of additional photoreactive groups such as acrylate groups [7]. The adhesion mechanism in PEG-based adhesives shows great variability because it is formulation-dependent [131]. FocalSeal-L is an FDA approved adhesive that is crosslinked by irradiation [4,132]. Generally, a PEG-PLA polymer is used, which has a low viscosity. After application to tissue, the PTMC-PEG polymer is added and polymerization is performed by irradiation in the presence of a photoinitiator [133]. This adhesive has been shown to be useful in thoracic surgery to prevent air leakage from suture lines [134]. Application during hemorrhage is difficult and almost impossible due to photoactivation. In an effort to solve this problem, products have been developed that do not require this process. CoSeal consists of two PEG polymers that rapidly crosslink with proteins in tissues and mechanically adhere to synthetic materials [135]. Comparative tests of CoSeal with traditional hemostatic agents such as gelfoam/thrombin for the treatment of anastomotic bleeding have confirmed its efficacy and safety. CoSeal is used in Europe in vascular and cardiac surgery to protect against anastomotic leakage [136,137]. It is indicated for reinforcing sutures and staple lines that may be sources of leakage. Another FDA-approved sealant adhesive is Duraseal, which consists of polyethylene glycol and a solution of trilysine amine. Mixing these two ingredients results in a nontoxic hydrogel with a 3D network. The benefits of the adhesive during sciatic nerve regeneration have also been demonstrated, with treatment results comparable to the traditional method using sutures [138]. SprayGel is a hydrogel that is sprayed onto tissue, where it hydrolyzes after a few days and is then absorbed. This polymer gel has been shown to be safe for use in gynecological procedures and colorectal surgery, including for ileostomy closure [139,140]. AdvaSeal is a PEG-based bioabsorbable photocrosslinker used clinically to seal pulmonary air leakage. Tanaka et al. [141] also demonstrated its efficacy in the treatment of acute aortic dissection.
For PEG-based systems, biodegradation takes 1–6 weeks. The weaknesses of PEG-based adhesive are high swelling after application and its poor adhesion to surrounding tissue. Therefore, one should be careful when using this adhesive in body cavities with limited volume [142].

3.3. Urethane-Based Adhesives

Among synthetic materials, urethane-based adhesives are not common. These adhesives are synthesized into prepolymer forms, so that they have the ability to react with the amino groups of proteins that are present in the biological environment and promote adhesion between tissues through the formation of urea bonds. PCL is biodegradable aliphatic polyester that has been approved by the US FDA and has been used as a drug delivery system [143] in the form of absorbable sutures [144] and as a tissue regeneration material [145]. To overcome the drawback of the prolonged curing time of the material, Ferreira et al. [146] presented the modification of polycaprolactone diol (PCL) with isocyanatoethyl 2-methacrylate (IEMA) to form a macromer that will be easily crosslinked by UV irradiation. UV-curable adhesives offer good process control and acceptable cure rates. They have been shown to be well tolerated by various cells and over a wide range of chemical concentrations [147]. Lipatova et al. [72] describes the synthesis of a polyurethane-based adhesive that has already been tested in renal surgery [148] and orthopedic procedures [149], and no toxic effects were observed. Phaneuf and team [150] presented the composition of a new adhesive, consisting of polyurethane based on polyethers containing carboxylic acid groups, which can seal the gaps of vascular prostheses. TissuGlu surgical adhesive is one of the commercially available urethane-based adhesives, and it has been registered for abdominal shell bonding [151]. On the surface of moist tissues, crosslinking occurs spontaneously and forms a strong bond between layers. The adhesive can be degraded by hydrolysis and enzymatic reactions in the presence of lysine. The degradation products are usually polyols (e.g., glycerol), lysine, ethanol, and carbon dioxide, which are water soluble and easily cleared from the body [152]. TissuGlu has been shown to be effective in plastic surgery in preventing seroma formation, which often occurs after abdominoplasty [152]. TissuGlu is nontoxic, absorbable, forms a strong bond between tissue layers, and contributes to the natural healing process.

3.4. Biomimetic Adhesives

Scientists are trying to use natural solutions observed in nature to create tissue adhesives. Of particular interest are certain species of snails, worms [153], clams, and geckos. Clams, which are commonly associated as delicacies, have been well studied as a potential source of waterproof adhesive [152,154]. Clams produce and secrete special adhesive substances. These enable them to adhere to substrates in marine environments, which are typically characterized by high salinity, humidity, and turbulence induced by sea waves. Mussel secretions contain proteins and enzymes that have specific adhesive properties, are nontoxic and noninflammatory, and are fully biodegradable [3,155,156]. These proteins are highly abundant in lysine and 3,4-dihydroxyphenyl-L-alanine (DOPA), which contains a catechol functional group [157,158]. The strong adhesion of clams to surfaces is believed to be based on strong covalent and noncovalent binding to surfaces covered by phenolic hydroxyl groups of DOPA or quinone groups [159]. Strong and water-insoluble adhesives from mussels have attracted interest for potential applications in medicine. They can be used as adhesives to bind cells and tissues together. Adhesives are generally environmentally friendly and apparently harmless to the human body and immune system [30,160,161,162]. Despite the identification of the major protein responsible for the adhesive properties and a thorough study of its properties, the practical application of the adhesive based on substances secreted by bivalves is limited. Uneconomical extraction and unsuccessful large-scale production limit the potential use of these adhesives in clinical practice. Obtaining adequate quantities of clams is labor intensive and inefficient [163,164,165]. The chemical extraction process used does not yield pure or individual adhesive proteins. Therefore, the development of clam adhesive has not yet been commercialized.
The ability of gecko to adhere to rough, smooth, vertical, and inverted substrates has led researchers to investigate the morphology and adhesive properties of gecko foot surfaces [166]. Autumn et al. [167] showed that the fibrillar ranks that cover the surface of a gecko’s foot maximize adhesion to surfaces, primarily through adhesive pads that are decorated with a dense set of bristles. Each bristle has multiple spatulas of 200–500 nm in length. The adhesion of the latter to surfaces is controlled by van der Waals forces [168]. Philip Messersmith and his team [169] at Northwestern University in Illinois have combined the techniques by which geckos and bivalves attach to different substrates. In doing so, they created an unusual adhesive substance. The hybrid, bioinspired adhesive consists of an array of nanofibrous polymer fibrils coated with a thin layer of synthetic polymer that mimics wet clam adhesive proteins. The adhesion strength under wet conditions of the nanostructured polymer pillars increased nearly 15-fold when coated with the clam-produced polymer [169]. The system retains its adhesion for over a thousand contact cycles in dry or wet environments. This hybrid adhesive, which combines the characteristic elements of both gecko and clam adhesion, should be useful for reversibly attaching components to various surfaces in any environment. In a study by Mahdavi and Ferreira et. al, [170] a biocompatible and biodegradable gecko-inspired tissue adhesive was developed from a combination of an elastomer and a thin film covering the surface. The adhesive is based on sebacic acid glycerol polyacrylate (PGSA) and a tough biodegradable elastomer with elastic properties. The authors have developed an adhesive with a promising covalent bond to wet tissue that may have applications in medical therapies as a waterproof adhesive to seal anastomoses, adjunctively for the treatment of hernias, ulcers, and burns, and even as a hemostatic agent in wound dressings.
A team of researchers at Harvard University has developed an innovative tissue adhesive modeled after the mucus produced by the snail species Arion fuscus [171]. The adhesive exhibits strong adhesion properties to a variety of wet surfaces, including tissue. The adhesive was tested on a beating pig heart, where it was subjected to high pressure. No leakage was demonstrated even when the heart muscle cells were stretched to the maximum. The adhesive can be used as a hemostatic dressing due to its biocompatibility with blood. The adhesive was able to effectively stop acute hemorrhage induced in rat liver. In vitro studies on human fibroblasts showed excellent biocompatibility. The combination of strong adhesion and high deformability could also be used to close skin wounds. Additionally, the adhesive could be used to implant medical devices that support human organs. This adhesive could make a veritable revolution in the way surgical patients are treated in the future [171].
Researchers from China decided to develop an adhesive based on egg white. As one of the most beneficial foods in nature, egg white is inherently nontoxic, biocompatible, and biodegradable. It is abundant in nature, which is associated with the low cost of adhesive manufacturing [172]. The dried protein powder can form a very viscous gel when mixed with a small portion of water. Slides (25 mm × 20 mm) coated with the adhesive can support a weight of 6 kg [172]. During testing, the adhesive at a ratio of 0.875 g of powder per ml of water showed the best injectability from a syringe needle and excellent plasticity and adhesion ability. Because of the irreversible protein aggregation formed during the air-drying process, the adhesion mechanism could be explained by the formation of a hydrogen bonding network and the conformational change of the egg white. A study was conducted on rats using a wound closure adhesive. The effects of treatment were evaluated after 5 days. Normal wound healing without inflammatory reaction or infection was observed [172]. Adhesive from fresh eggs can be produced by air-drying, grinding and mixing with the right amount of water. The resulting adhesive had excellent adhesion strength on various types of substrates and good adhesion under water compared to common commercial medical adhesives. Subcutaneous degradation analysis of the adhesive showed no strong long-term inflammatory response in vivo. Considering its very low production cost and environmentally friendly processing steps, it has a future as a medical adhesive [172].

4. Stem Cells in Medical Adhesive Application

Stem cells possess abilities allowing them to differentiate into a plethora of lineage-specific cell types. Despite the primary interest in embryonic stem cells, currently the major focus has been driven towards adult stem cells for the use of tissue repair [173,174]. Adult stem cells are present in several tissues and organs, including the blood vessels, brain, pancreas, or liver [175]. Most commonly, however, mesenchymal stromal cells (MSCs) are derived and gathered from adipose tissue and bone marrow, where they can be collected with use of noninvasive methods [176].
MSCs play a fundamental role in the process of tissue healing, modulating the production of crucial cytokines [177,178,179]. Stem cells’ abilities of promoting angiogenesis and differentiating into various cell types allow them to take an important part in the wound repair process when they are combined with the fibrin matrix [180].
The cutaneous wound healing process is a complex procedure that requires well-coordinated molecular and biological steps in the form of cell migration, angiogenesis, and remodeling [181]. Wu et al. [176], as well as Branski et al. [182], confirmed that both bone marrow stem cells (BMSC) and adipose-derived stem cells (ADSC) are able to enhance the epithelization of cutaneous wounds. Additionally, ADSCs have the potential to induce cellular differentiation towards keratinocytes [183] and enhance the proliferation of fibroblasts [184].
Due to the regenerative properties of MSCs, there have been strategies considering delivering such cells to the site of the injured tissues. According to Ortiz et al. [177], MSCs can be successfully injected directly to the injured site with or without use of biocompatible scaffolds. One of the many examples of stem cell utility in tissue regeneration can be achieved with muscle-derived stem cells, which can enable the regeneration of even critical-sized bone defects [185].
Fibrin adhesive is a noncytotoxic and biocompatible polymer that is naturally biodegradable with the use of the fibrinolytic enzymes of the human body. According to the study [186], fibrin adhesive can be characterized as a highly valuable biomaterial that is capable of delivering vital cells to injured tissues.
Nowadays, tissue engineering is used in attempts to treat a variety of tissue defects that are the result of traumatic injury, but also those that arise during the process of development. Direct injection of cells into the injured tissue gives poor results. A scaffold is usually required to start the proper regeneration process. In the case of regeneration enhancement, fibrin can be used alone or in a combination with specific scaffolds [187]. There are studies confirming the usability of fibrin adhesive as a potential scaffold itself, as well as cell carrier in tissue regeneration [188].
A study [189] confirmed the superiority of using a fibrin gel consisting of autologous rabbit fibrin beads over untreated tibial defects. Another study [190] confirmed the high clinical importance of stem cell-enriched fibrin adhesive in dog bone defects.
The systematic review based on in vivo and in vitro studies confirmed that medical adhesives such as fibrin gel are a suitable carrier and scaffold for stem cell application in case of tissue injuries. Advances in research are still required in order to fully understand the process, yet the whole method has proven to be medically important and promising.

5. Discussion

Medical adhesives are becoming more and more popular each year with the studies confirming their utility in regenerative medicine. Generally, suturing in laparoscopic procedures is a most commonly used method for closing the wounds. Yet, the placement of sutures via a laparoscope is a technically challenging and time-consuming method. On the other hand, it has already been confirmed that the use of adhesives in laparoscopic surgeries enables control over bleeding, as well as reinforces the anastomoses. When it comes to the division of adhesives, they can be distinguished according to their origin, natural and synthetic. Among the natural ones, fibrin, together with collagen and gelatin, are one of the most commonly used adhesives.
Fibrin sealants possess features of an excellent template for cellular migrations, supporting keratinocyte and fibroblast growth [191]. Apart from being a hemostatic agent, fibrin sealants can be successfully used in a plethora of clinical situations, including the treatment of gastrointestinal anastomosis leakage, perforated ulcers, or trauma to organs such as the spleen. Research has confirmed that fibrin adhesives can be safely delivered to sites of infection based on animal models.
Collagen sealants have been checked for increased hemostatic activity due to their influence on the platelet adhesion in blood. There are studies [192,193] confirming the increased strength of sealants and adhesives containing collagen fibers.
Gelatin-based adhesives are mostly made of gelatin, which is an irreversibly denatured collagen and a base material for hemostat products. Research confirms that these adhesives can be successfully used in controlling minor bone or vessel bleeding [194].
The second group of adhesives is synthetic. Cyanoacrylate and various other artificial adhesives were invented in order to make up for the weak strength of natural-derived glues. Even though the cyanoacrylate adhesives possess higher strength, potential risks of infections and cytotoxicity were raised [195]. For this reason, the current development of synthetic adhesives focuses on polyethylene glycol or polyurethane-based adhesives.
Nowadays, research concerning adhesives is focused on improving their mechanical properties in order to achieve fully sutureless medical procedures. It is important to underline that most adhesives require applying proper pressure in order to fully stop the hemorrhage. This can be challenging in laparoscopic surgeries due to the limited amount of surgical field and access to the wound. That is why it is important to develop adhesive materials that will become more advanced, with the emphasis on increased mechanical characteristics as well as shortened curing time.
Because of the laparoscopic revolution, the need for enhanced adhesives is even greater than before. Future research should focus on assessing the bioactivity and biocompatibility of new adhesives while maintaining their suitable mechanical characteristics. It should be important to explore the biomechanical properties of native tissues in order for clinicians to better understand the nature and mechanics behind effective adhesives.

6. Summary

Over the past several years, thanks to the development of biotechnology, tissue adhesives have changed their composition and structure by modifying existing biomaterials and creating new ones. Some adhesives can be applied topically to the inside of tissues and externally to their surfaces. They are available in various forms (liquid, powder, and sponge). In vitro studies are important for the further development of new materials for in vivo applications. The variety of medical adhesive applications is shown in Table 1. The efficacy of the selected adhesives has already been confirmed, while a large number of new bonding materials await further research. When selecting a tissue adhesive for a specific surgical procedure, cost, side effects, and efficacy must be considered. Some new adhesives show stronger performance compared to those already commercially used. More clinical trials are needed to commercialize new biomaterials. In the future, new tissue adhesives may be designed by mimicking solutions that occur naturally in the environment. The bioengineering of proteins and DNA gene biotechnology has the manufacturing potential to create an adhesive with unique properties. Adhesion strength is one of the most important parameters, so it is important to standardize the tests that tissue adhesives undergo [196]. In addition, more attention should be paid to the matching of the mechanical properties between the adhesive and the target tissue [47]. It is widely believed that adhesives will eventually replace sutures and staplers in surgical procedures, although it is difficult to predict when exactly this will occur.

Author Contributions

Conceptualization, Z.R., M.M. and W.Z.; methodology, Z.R., W.Z. and M.M.; software, W.Z.; validation, M.S. and Z.R.; formal analysis, M.M.; investigation, M.M.; resources, M.M. and W.Z.; data curation, M.S. and Z.R.; writing—original draft preparation, M.M. and W.Z.; writing—review and editing, M.M. and W.Z.; visualization, M.M. and W.Z.; supervision, M.S. and Z.R.; project administration, M.S. and Z.R.; funding acquisition, Z.R. and M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

This work was financed by a subsidy from Wroclaw Medical University, Wroclaw, Poland, number SUBK.Z516.22.053 and SUBZ.Z516.22.011.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Onusseit, H. Praxiswissen Klebtechnik: Band 1: Grundlagen; Beuth: Berlin/Heidelberg, Germany, 2008. [Google Scholar]
  2. Brockmann, W. Adhesive Bonding: Materials, Applications and Technology; Wiley-VCH: Weinheim, Germany, 2009; ISBN 978-3-527-62393-8. [Google Scholar]
  3. Park, K.H.; Seong, K.Y.; Yang, S.Y.; Seo, S. Advances in medical adhesives inspired by aquatic organisms’ adhesion. Biomater. Res. 2017, 21, 16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ge, L.; Chen, S. Recent Advances in Tissue Adhesives for Clinical Medicine. Polymers 2020, 12, 939. [Google Scholar] [CrossRef] [PubMed]
  5. Annabi, N.; Tamayol, A.; Shin, S.R.; Ghaemmaghami, A.M.; Peppas, N.A.; Khademhosseini, A. Surgical Materials: Current Challenges and Nano-enabled Solutions. Nano Today 2014, 9, 574–589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Bré, L.P.; Zheng, Y.; Pêgo, A.P.; Wang, W. Taking tissue adhesives to the future: From traditional synthetic to new biomimetic approaches. Biomater. Sci. 2013, 1, 239–253. [Google Scholar] [CrossRef] [PubMed]
  7. Bouten, P.J.M.; Zonjee, M.; Bender, J.; Yauw, S.T.K.; Van Goor, H.; Van Hest, J.C.M.; Hoogenboom, R. The chemistry of tissue adhesive materials. Prog. Polym. Sci. 2014, 7, 1375–1405. [Google Scholar] [CrossRef]
  8. García Páez, J.M.; Jorge Herrero, E.; Rocha, A.; Maestro, M.; Castillo-Olivares, J.L.; Millan, I.; Carrera Sanmartin, A.; Cordon, A. Comparative study of the mechanical behaviour of a cyanoacrylate and a bioadhesive. J. Mater. Sci. Mater. Med. 2004, 15, 109–115. [Google Scholar] [CrossRef]
  9. Beckman, E.J.; Buckley, M.; Agarwal, S.; Zhang, J. Medical Adhesive and Methods of Tissue Adhesion. U.S. Patent 7264823, 4 September 2007. [Google Scholar]
  10. Kull, S.; Martinelli, I.; Briganti, E.; Losi, P.; Spiller, D.; Tonlorenzi, S.; Soldani, G. Glubran2 surgical glue: In vitro evaluation of adhesive and mechanical properties. J. Surg. Res. 2009, 157, e15–e21. [Google Scholar] [CrossRef]
  11. Lauto, A.; Mawad, D.; Foster, L.J.R. Adhesive biomaterials for tissue reconstruction. J. Chem. Technol. Biotechnol. 2008, 83, 464–472. [Google Scholar] [CrossRef]
  12. Sharma, B.; Fermanian, S.; Gibson, M.; Unterman, S.; Herzka, D.A.; Cascio, B.; Coburn, J.; Hui, A.Y.; Marcus, N.; Gold, G.E.; et al. Human cartilage repair with a photoreactive adhesive-hydrogel composite. Sci. Transl. Med. 2013, 5, 167ra6. [Google Scholar] [CrossRef] [Green Version]
  13. Gittens, R.A.; Olivares-Navarrete, R.; Schwartz, Z.; Boyan, B.D. Implant osseointegration and the role of microroughness and nanostructures: Lessons for spine implants. Acta Biomater. 2014, 10, 3363–3371. [Google Scholar] [CrossRef] [Green Version]
  14. Avila, G.; Misch, K.; Galindo-Moreno, P.; Wang, H.L. Implant surface treatment using biomimetic agents. Implant Dent. 2009, 18, 17–26. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, Y.; Li, J.P.; Hunziker, E.B.; De Groot, K. Incorporation of growth factors into medical devices via biomimetic coatings. Philos. Trans. R. Soc. A Math. Phys. Eng. Sci. 2005, 364, 233–248. [Google Scholar] [CrossRef]
  16. Richards, R.G.; Moriarty, T.F.; Miclau, T.; McClellan, R.T.; Grainger, D.W. Advances in biomaterials and surface technologies. J. Orthop. Trauma 2012, 26, 703–707. [Google Scholar] [CrossRef] [PubMed]
  17. Ceylan, H.; Kocabey, S.; Unal Gulsuner, H.; Balcik, O.S.; Guler, M.O.; Tekinay, A.B. Bone-like mineral nucleating peptide nanofibers induce differentiation of human mesenchymal stem cells into mature osteoblasts. Biomacromolecules 2014, 15, 2407–2418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Kang, S.M.; Hwang, N.S.; Yeom, J.; Park, S.Y.; Messersmith, P.B.; Choi, I.S.; Langer, R.; Anderson, D.G.; Lee, H. One-Step Multipurpose Surface Functionalization by Adhesive Catecholamine. Adv. Funct. Mater. 2012, 22, 2949–2955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Reece, T.B.; Maxey, T.S.; Kron, I.L. A prospectus on tissue adhesives. Am. J. Surg. 2001, 182, S40–S44. [Google Scholar] [CrossRef]
  20. Portilla-de Buen, E.; Orozco-Mosqueda, A.; Leal-Cortés, C.; Vázquez-Camacho, G.; Fuentes-Orozco, C.; Alvarez-Villaseñor, A.S.; Macías-Amezcua, M.D.; González-Ojeda, A. Fibrinogen and thrombin concentrations are critical for fibrin glue adherence in rat high-risk colon anastomoses. Clinics 2014, 69, 259–264. [Google Scholar] [CrossRef]
  21. Spotnitz, W.D.; Dalton, M.S.; Baker, J.W.; Nolan, S.P. Reduction of perioperative hemorrhage by anterior mediastinal spray application of fibrin glue during cardiac operations. Ann. Thorac. Surg. 1987, 44, 529–531. [Google Scholar] [CrossRef]
  22. Borst, H.G.; Haverich, A.; Walterbusch, G.; Maatz, W. Fibrin adhesive: An important hemostatic adjunct in cardiovascular operations. J. Thorac. Cardiovasc. Surg. 1982, 84, 548–553. [Google Scholar] [CrossRef]
  23. Séguin, J.R.; Picard, E.; Frapier, J.M.; Chaptal, P.A. Aortic valve repair with fibrin glue for type A acute aortic dissection. Ann. Thorac. Surg. 1994, 58, 304–307. [Google Scholar] [CrossRef]
  24. Saltz, R. Tissue Glues in Cosmetic Surgery; Dean, T., Ed.; Thieme Medical Publishers Inc.: Leipzig, Germany, 2004; ISBN 1576261743. [Google Scholar]
  25. Quinn, J.V. Tissue Adhesives in Clinical Medicine; PMPH USA, Ltd.: Shelton, CT, USA, 2005; p. 183. [Google Scholar]
  26. Spotnitz, W.D.; Falstrom, J.K.; Rodeheaver, G.T. The role of sutures and fibrin sealant in wound healing. Surg. Clin. N. Am. 1997, 77, 651–669. [Google Scholar] [CrossRef]
  27. Schenk, W.G.; Burks, S.G.; Gagne, P.J.; Kagan, S.A.; Lawson, J.H.; Spotnitz, W.D. Fibrin sealant improves hemostasis in peripheral vascular surgery: A randomized prospective trial. Ann. Surg. 2003, 237, 871–876. [Google Scholar] [CrossRef] [PubMed]
  28. Barros, L.C.; Ferreira, R.S.; Barraviera, S.R.C.S.; Stolf, H.O.; Thomazini-Santos, I.A.; Mendes-Giannini, M.J.S.; Toscano, E.; Barraviera, B. A new fibrin sealant from crotalus durissus terrificus venom: Applications in medicine. J. Toxicol. Environ. Health Part B Crit. Rev. 2009, 12, 553–571. [Google Scholar] [CrossRef] [PubMed]
  29. Wax, M.K.; Ramadan, H.H.; Ortiz, O.; Wetmore, S.J. Contemporary management of cerebrospinal fluid rhinorrhea. Otolaryngol. Head. Neck Surg. 1997, 116, 442–449. [Google Scholar] [CrossRef]
  30. Strausberg, R.L.; Link, R.P. Protein-based medical adhesives. Trends Biotechnol. 1990, 8, 53–57. [Google Scholar] [CrossRef]
  31. Sawamura, Y.; Asaoka, K.; Terasaka, S.; Tada, M.; Uchida, T. Evaluation of application techniques of fibrin sealant to prevent cerebrospinal fluid leakage: A new device for the application of aerosolized fibrin glue. Neurosurgery 1999, 44, 332–337. [Google Scholar] [CrossRef]
  32. Shaffrey, C.I.; Spotnitz, W.D.; Shaffrey, M.E.; Jane, J.A.; Laws, E.R.; Sekhar, L.N.; Al-Mefty, O. Neurosurgical Applications of Fibrin Glue: Augmentation of Dural Closure in 134 Patients. Neurosurgery 1990, 26, 207–210. [Google Scholar] [CrossRef]
  33. Stuart, J.D.; Kenney, J.G.; Lettieri, J.; Spotnitz, W.; Baker, J. Application of single-donor fibrin glue to burns. J. Burn Care Rehabil. 1988, 9, 619–622. [Google Scholar] [CrossRef]
  34. Mutignani, M.; Iacopini, F.; Dokas, S.; Larghi, A.; Familiari, P.; Tringali, A.; Costamagna, G. Successful endoscopic closure of a lateral duodenal perforation at ERCP with fibrin glue. Gastrointest. Endosc. 2006, 63, 725–727. [Google Scholar] [CrossRef]
  35. Chandra, P.; Phalgune, D.; Shah, S. Comparison of the Clinical Outcome and Complications in Laparoscopic Hernia Repair of Inguinal Hernia With Mesh Fixation Using Fibrin Glue vs Tacker. Indian J. Surg. 2016, 78, 464–470. [Google Scholar] [CrossRef] [Green Version]
  36. Ferrarese, A.; Marola, S.; Surace, A.; Borello, A.; Bindi, M.; Cumbo, J.; Solej, M.; Enrico, S.; Nano, M.; Martino, V. Fibrin glue versus stapler fixation in laparoscopic transabdominal inguinal hernia repair: A single center 5-year experience and analysis of the results in the elderly. Int. J. Surg. 2014, 12 (Suppl. S2), S94–S98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Zhou, X.; Zhang, Q.; Song, W.; Zhou, D.; He, Y. Clinical significance of three-dimensional skeleton-arterial model in the management of delayed reconstruction of acetabular fractures. BMC Surg. 2018, 18, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Samuels, L.E.; Shaw, P.M.; Blaum, L.C. Percutaneous technique for management of persistent airspace with prolonged air leak using fibrin glue. Chest 1996, 109, 1653–1655. [Google Scholar] [CrossRef] [Green Version]
  39. York, E.L.; Lewall, D.B.; Hirji, M.; Gelfand, E.T.; Modry, D.L. Endoscopic diagnosis and treatment of postoperative bronchopleural fistula. Chest 1990, 97, 1390–1392. [Google Scholar] [CrossRef]
  40. Drovandi, L.; Cianchi, I.; Pratesi, S.; Dani, C. Fibrin glue pleurodesis for pneumothorax in extremely preterm infants: A case report and literature review. Ital. J. Pediatr. 2018, 44, 91. [Google Scholar] [CrossRef]
  41. Presser, N.; Kerr, H.; Gao, T.; Begala, M.; Paschal, S.; Shoskes, D.A.; Flechner, S.M. Fibrin Glue Injections: A Minimally Invasive and Cost-Effective Treatment for Post-Renal Transplant Lymphoceles and Lymph Fistulas. Am. J. Transpl. 2016, 16, 694–699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Gregor, R.T. Management of chyle fistulization in association with neck dissection. Otolaryngol. Head. Neck Surg. 2000, 122, 434–439. [Google Scholar] [CrossRef]
  43. Levy, O.; Martinowitz, U.; Oran, A.; Tauber, C.; Horoszowski, H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J. Bone Jt. Surg. Am. 1999, 81, 1580–1588. [Google Scholar] [CrossRef]
  44. Hu, Y.; Yu, T.; Liu, X.; He, Y.; Deng, L.; Guo, J.; Hua, Y.; Luo, T.; Gao, X. Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer. Oncotarget 2018, 9, 2515. [Google Scholar] [CrossRef] [Green Version]
  45. Koulaxouzidis, G.; Reim, G.; Witzel, C. Fibrin glue repair leads to enhanced axonal elongation during early peripheral nerve regeneration in an in vivo mouse model. Neural Regen. Res. 2015, 10, 1166. [Google Scholar] [CrossRef]
  46. Jungnickel, J.; Haase, K.; Konitzer, J.; Timmer, M.; Grothe, C. Faster nerve regeneration after sciatic nerve injury in mice over-expressing basic fibroblast growth factor. J. Neurobiol. 2006, 66, 940–948. [Google Scholar] [CrossRef]
  47. Peng, H.T.; Shek, P.N. Novel wound sealants: Biomaterials and applications. Expert Rev. Med. Devices 2010, 7, 639–659. [Google Scholar] [CrossRef]
  48. Scheyer, M.; Zimmermann, G. Tachocomb used in endoscopic surgery. Surg. Endosc. 1996, 10, 501–503. [Google Scholar] [CrossRef]
  49. Schiele, U.; Kuntz, G.; Riegler, A. Haemostyptic preparations on the basis of collagen alone and as fixed combination with fibrin glue. Clin. Mater. 1992, 9, 169–177. [Google Scholar] [CrossRef]
  50. Kim, Y.W.; Kang, M.J.; Lee, H.J.; Woo, C.K.; Mun, M.J.; Cho, K.S. The efficacy of TachoComb on reducing postoperative complications after tonsillectomy in children. Int. J. Pediatr. Otorhinolaryngol. 2015, 79, 1337–1340. [Google Scholar] [CrossRef]
  51. Horowitz, B.; Busch, M. Estimating the pathogen safety of manufactured human plasma products: Application to fibrin sealants and to thrombin. Transfusion 2008, 48, 1739. [Google Scholar] [CrossRef]
  52. Busuttil, R.W. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J. Am. Coll. Surg. 2003, 197, 1021–1028. [Google Scholar] [CrossRef]
  53. Oswald, A.M.; Joly, L.M.; Gury, C.; Disdet, M.; Leduc, V.; Kanny, G. Fatal Intraoperative Anaphylaxis Related to Aprotinin after Local Application of Fibrin Glue. Anesthesiology 2003, 99, 762–763. [Google Scholar] [CrossRef]
  54. Spotnitz, W.D. Fibrin sealant: Past, present, and future: A brief review. World J. Surg. 2010, 34, 632–634. [Google Scholar] [CrossRef]
  55. Wheat, J.C.; Wolf, J.S. Advances in bioadhesives, tissue sealants, and hemostatic agents. Urol. Clin. N. Am. 2009, 36, 265–275. [Google Scholar] [CrossRef]
  56. Currie, L.J.; Sharpe, J.R.; Martin, R. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: A review. Plast. Reconstr. Surg. 2001, 108, 1713–1726. [Google Scholar] [CrossRef]
  57. Bjork, J.W.; Johnson, S.L.; Tranquillo, R.T. Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue. Biomaterials 2011, 32, 2479–2488. [Google Scholar] [CrossRef] [Green Version]
  58. Farndale, R.W.; Sixma, J.J.; Barnes, M.J.; De Groot, P.G. The role of collagen in thrombosis and hemostasis. J. Thromb. Haemost. 2004, 2, 561–573. [Google Scholar] [CrossRef]
  59. Zhang, F.; Liu, J.; Wu, Y.; Jin, L.; Wang, Y.; Xu, Z. Study on the adsorption properties of multiple-generation hyperbranched collagen fibers towards isolan-series acid dyes. RSC Adv. 2022, 12, 6855–6868. [Google Scholar] [CrossRef]
  60. Echave, M.; Oyagöez, I.; Casado, M.A. Use of Floseal®, a human gelatine-Thrombin matrix sealant, in surgery: A systematic review. BMC Surg. 2014, 14, 111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Ryou, M.; Thompson, C.C. Tissue Adhesives: A Review. Tech. Gastrointest. Endosc. 2006, 8, 33–37. [Google Scholar] [CrossRef]
  62. Moldovan, H.; Antoniac, I.; Gheorghiță, D.; Safta, M.S.; Preda, S.; Broască, M.; Badilă, E.; Fronea, O.; Scafa-Udrişte, A.; Cacoveanu, M.; et al. Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends. Polymers 2022, 14, 1189. [Google Scholar] [CrossRef]
  63. Milkes, D.E.; Friedland, S.; Lin, O.S.; Reid, T.R.; Soetikno, R.M. A novel method to control severe upper GI bleeding from metastatic cancer with a hemostatic sealant: The CoStasis surgical hemostat. Gastrointest. Endosc. 2002, 55, 735–740. [Google Scholar] [CrossRef]
  64. Liu, Y.; Kopelman, D.; Wu, L.Q.; Hijji, K.; Attar, I.; Preiss-Bloom, O.; Payne, G.F. Biomimetic sealant based on gelatin and microbial transglutaminase: An initial in vivo investigation. J. Biomed. Mater. Res. 2009, 91, 5–16. [Google Scholar] [CrossRef]
  65. Gowda, A.H.J.; Bu, Y.; Kudina, O.; Krishna, K.V.; Bohara, R.A.; Eglin, D.; Pandit, A. Design of tunable gelatin-dopamine based bioadhesives. Int. J. Biol. Macromol. 2020, 164, 1384–1391. [Google Scholar] [CrossRef]
  66. Ulubayram, K.; Aksu, E.; Gurhan, S.I.D.; Serbetci, K.; Hasirci, N. Cytotoxicity evaluation of gelatin sponges prepared with different cross-linking agents. J. Biomater. Sci. Polym. Ed. 2012, 13, 1203–1219. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Elvin, C.M.; Vuocolo, T.; Brownlee, A.G.; Sando, L.; Huson, M.G.; Liyou, N.E.; Stockwell, P.R.; Lyons, R.E.; Kim, M.; Edwards, G.A.; et al. A highly elastic tissue sealant based on photopolymerised gelatin. Biomaterials 2010, 31, 8323–8331. [Google Scholar] [CrossRef] [PubMed]
  68. Chen, T.; Embree, H.D.; Brown, E.M.; Taylor, M.M.; Payne, G.F. Enzyme-catalyzed gel formation of gelatin and chitosan: Potential for in situ applications. Biomaterials 2003, 24, 2831–2841. [Google Scholar] [CrossRef]
  69. Chen, T.; Janjua, R.; McDermott, M.K.; Bernstein, S.L.; Steidl, S.M.; Payne, G.F. Gelatin-based biomimetic tissue adhesive. Potential for retinal reattachment. J. Biomed. Mater. Res. 2006, 77, 416–422. [Google Scholar] [CrossRef]
  70. Küçükaksu, D.S.; Akgül, A.; Çagli, K.; Taşdemir, O. Beneficial Effect of BioGlue® Surgical Adhesive in Repair of Iatrogenic Aortic Dissection. Texas Hear. Inst. J. 2000, 27, 307. [Google Scholar]
  71. Oz, M.C.; Rondinone, J.F.; Shargill, N.S. FloSeal Matrix: New generation topical hemostatic sealant. J. Card. Surg. 2003, 18, 486–493. [Google Scholar] [CrossRef] [PubMed]
  72. Lipatova, T.E. Medical polymer adhesives. Adv. Polym. Sci. 1986, 79, 65–93. [Google Scholar] [CrossRef]
  73. Nomori, H.; Horio, H.; Suemasu, K. The efficacy and side effects of gelatin-resorcinol formaldehyde-glutaraldehyde (GRFG) glue for preventing and sealing pulmonary air leakage. Surg. Today 2000, 30, 244–248. [Google Scholar] [CrossRef]
  74. BioGlue Surgical Adhesive. Biomed. Saf. Stand. 2014, 44, 118. [CrossRef]
  75. Lee, D.I.; Uribe, C.; Eichel, L.; Khonsari, S.; Basillote, J.; Park, H.K.; Li, C.C.; McDougall, E.M.; Clayman, R.V. Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: Initial clinical use. J. Urol. 2004, 171, 575–578. [Google Scholar] [CrossRef]
  76. Nomori, H.; Horio, H.; Morinaga, S.; Suemasu, K. Gelatin-resorcinol-formaldehyde-glutaraldehyde glue for sealing pulmonary air leaks during thoracoscopic operation. Ann. Thorac. Surg. 1999, 67, 212–216. [Google Scholar] [CrossRef]
  77. Gregory, K. Wound Dressing and Method for Controlling Severe, Life-Threatening Bleeding. U.S. Patent US7482503B2, 14 June 2001. [Google Scholar]
  78. Pusateri, A.E.; Mccarthy, S.J.; Gregory, K.W.; Harris, R.A.; Cardenas, L.; Mcmanus, A.T.; Goodwin, C.W. Effect of a Chitosan-Based Hemostatic Dressing on Blood Loss and Survival in a Model of Severe Venous Hemorrhage and Hepatic Injury in Swine. J. Trauma Inj. Infect. Crit. Care 2003, 54, 177–182. [Google Scholar] [CrossRef] [Green Version]
  79. Wedmore, I.; McManus, J.G.; Pusateri, A.E.; Holcomb, J.B. A special report on the chitosan-based hemostatic dressing: Experience in current combat operations. J. Trauma 2006, 60, 655–658. [Google Scholar] [CrossRef] [Green Version]
  80. Brown, M.A.; Daya, M.R.; Worley, J.A. Experience with Chitosan Dressings in a Civilian EMS System. J. Emerg. Med. 2009, 37, 1–7. [Google Scholar] [CrossRef]
  81. Celox Medical Haemostatic Dressings: Chest Seal Dressings: Cellox Haemostats. Available online: https://www.celoxmedical.com/products/ (accessed on 14 February 2022).
  82. Kozen, B.G.; Kircher, S.J.; Henao, J.; Godinez, F.S.; Johnson, A.S. An alternative hemostatic dressing: Comparison of CELOX, HemCon, and QuikClot. Acad. Emerg. Med. 2008, 15, 74–81. [Google Scholar] [CrossRef]
  83. Kheirabadi, B.S.; Edens, J.W.; Terrazas, I.B.; Estep, J.S.; Klemcke, H.G.; Dubick, M.A.; Holcomb, J.B. Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. J. Trauma Inj. Infect. Crit. Care 2009, 66, 316–326. [Google Scholar] [CrossRef] [PubMed]
  84. Klokkevold, P.R.; Fukayama, H.; Sung, E.C.; Bertolami, C.N. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. J. Oral Maxillofac. Surg. 1999, 57, 49–52. [Google Scholar] [CrossRef]
  85. Lauto, A.; Foster, L.J.; Avolio, A.; Sampson, D.; Raston, C.; Sarris, M.; McKenzie, G.; Stoodley, M. Sutureless nerve repair with laser-activated chitosan adhesive: A pilot in vivo study. Photomed. Laser Surg. 2008, 26, 227–234. [Google Scholar] [CrossRef] [Green Version]
  86. Lauto, A.; Stoodley, M.; Marcel, H.; Avolio, A.; Sarris, M.; McKenzie, G.; Sampson, D.D.; Foster, L.J.R. In vitro and in vivo tissue repair with laser-activated chitosan adhesive. Lasers Surg. Med. 2007, 39, 19–27. [Google Scholar] [CrossRef]
  87. Ishihara, M. Photocrosslinkable Chitosan Hydrogel as a Wound Dressing and a Biological Adhesive. Trends Glycosci. Glycotechnol. 2002, 14, 331–341. [Google Scholar] [CrossRef]
  88. Nakayama, Y.; Matsuda, T. Photocurable surgical tissue adhesive glues composed of photoreactive gelatin and poly(ethylene glycol) diacrylate. J. Biomed. Mater. Res. 1999, 48, 511–521. [Google Scholar] [CrossRef]
  89. Garcia, P.; Mines, M.J.; Bower, K.S.; Hill, J.; Menon, J.; Tremblay, E.; Smith, B. Robotic laser tissue welding of sclera using chitosan films. Lasers Surg. Med. 2009, 41, 59–67. [Google Scholar] [CrossRef]
  90. Hoekstra, A.; Struszczyk, H.; Kivekäs, O. Percutaneous microcrystalline chitosan application for sealing arterial puncture sites. Biomaterials 1998, 19, 1467–1471. [Google Scholar] [CrossRef]
  91. Baeurle, S.A.; Kiselev, M.G.; Makarova, E.S.; Nogovitsin, E.A. Effect of the counterion behavior on the frictional-compressive properties of chondroitin sulfate solutions. Polymer 2009, 50, 1805–1813. [Google Scholar] [CrossRef]
  92. Shin, J.; Kang, E.H.; Choi, S.; Jeon, E.J.; Cho, J.H.; Kang, D.; Lee, H.; Yun, I.S.; Cho, S.W. Tissue-Adhesive Chondroitin Sulfate Hydrogel for Cartilage Reconstruction. ACS Biomater. Sci. Eng. 2021, 7, 4230–4243. [Google Scholar] [CrossRef] [PubMed]
  93. Wang, D.A.; Varghese, S.; Sharma, B.; Strehin, I.; Fermanian, S.; Gorham, J.; Fairbrother, D.H.; Cascio, B.; Elisseeff, J.H. Multifunctional chondroitin sulphate for cartilage tissue–biomaterial integration. Nat. Mater. 2007, 6, 385–392. [Google Scholar] [CrossRef]
  94. Pirouzmanesh, A.; Herretes, S.; Reyes, J.M.G.; Suwan-apichon, O.; Chuck, R.S.; Wang, D.A.; Elisseeff, J.H.; Stark, W.J.; Behrens, A. Modified microkeratome-assisted posterior lamellar keratoplasty using a tissue adhesive. Arch. Ophthalmol. 2006, 124, 210–214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Collito, M.B. Dental Methods Employing a Cyanoacrylate. U.S. Patent US3250002A, 26 February 1962. [Google Scholar]
  96. Coover, H.W.; Shearer, N.H. Single-Stage Mixed Monomer Adhesive Compositions. U.S. Patent US2763585A, 8 June 1954. [Google Scholar]
  97. Coover, H.W.; Shearer, N.H. Adhesive Compositions Containing Alkyl esters of Cyanoacrylic Acid. U.S. Patent US2794788A, 1 November 1952. [Google Scholar]
  98. Coover, H.W. Living Case Histories of Innovation: Cyanoacrylate Adhesives—A Day of Serendipity, A Decade of Hard Work. Res. Manag. 1980, 23, 37–40. [Google Scholar] [CrossRef]
  99. Erdmann, L.; Uhrich, K.E. Synthesis and degradation characteristics of salicylic acid-derived poly (anhydride-esters). Biomaterials 2000, 21, 1941–1946. [Google Scholar] [CrossRef]
  100. Leonard, F.; Collins, J.A.; Porter, H.J. Interfacial polymerization of n-alkyl α-cyanoacrylate homologs. J. Appl. Polym. Sci. 1966, 10, 1617–1623. [Google Scholar] [CrossRef]
  101. Coover, H.W.; Dreifus, D.W.; O’Connor, J.T. Cyanoacrylate Adhesives. Handb. Adhes. 1990, 463–477. [Google Scholar] [CrossRef]
  102. Petrie, E.M. Cyanoacrylate adhesives in surgical applications: A critical review. Rev. Adhes. Adhes. 2014, 2, 253–310. [Google Scholar] [CrossRef]
  103. Mattamal, G.J. U.S. FDA Perspective on the Regulation of Cyanoacrylate Polymer Tissue Adhesives in Clinical Applications. Mater. Sci. Forum 2007, 539–543, 692–697. [Google Scholar] [CrossRef]
  104. Chandra, S.; Holm, A.; El Abiad, R.G.; Gerke, H. Endoscopic Cyanoacrylate Glue Injection in Management of Gastric Variceal Bleeding: US Tertiary Care Center Experience. J. Clin. Exp. Hepatol. 2018, 8, 181–187. [Google Scholar] [CrossRef] [PubMed]
  105. Abdulmalak, G.; Chevallier, O.; Falvo, N.; Di Marco, L.; Bertaut, A.; Moulin, B.; Abi-Khalil, C.; Gehin, S.; Charles, P.E.; Latournerie, M.; et al. Safety and efficacy of transcatheter embolization with Glubran® 2 cyanoacrylate glue for acute arterial bleeding: A single-center experience with 104 patients. Abdom. Radiol. 2018, 43, 723–733. [Google Scholar] [CrossRef]
  106. Salah-Eldin Shehata, M.; Elkordy, M.; Abd-Elaal Nafe, M.; Farag Mohammed Radwan, A. Cyanoacrylate Glue Mesh Fixation versus Suture Mesh Fixation in Open Inguinal Hernia Repair. Egypt. J. Hosp. Med. 2017, 69, 2502–2511. [Google Scholar] [CrossRef]
  107. Nevins, M.; Mendoza-Azpur, G.; De Angelis, N.; Kim, D. The Biocompatibility of Cyanoacrylate Tissue Adhesive in Conjunction with a Collagen Membrane for Providing Soft and Hard Tissue Regeneration in Extraction Socket Preservation Procedures. Int. J. Periodontics Restor. Dent. 2018, 38, s37–s42. [Google Scholar] [CrossRef] [PubMed]
  108. Lima, T.C.; Vieira-Barbosa, N.M.; Grasielle de Sá Azevedo, C.; de Matos, F.R.; Douglas de Oliveira, D.W.; de Oliveira, E.S.; Ramos-Jorge, M.L.; Gonçalves, P.F.; Flecha, O.D. Oral Health-Related Quality of Life before and after Treatment of Dentin Hypersensitivity with Cyanoacrylate and Laser. J. Periodontol. 2017, 88, 166–172. [Google Scholar] [CrossRef] [PubMed]
  109. Liebelt, E.L. Current concepts in laceration repair. Curr. Opin. Pediatr. 1997, 9, 459–464. [Google Scholar] [CrossRef] [PubMed]
  110. Scheuer, C.; Boot, E.; Carse, N.; Clardy, A.; Gallagher, J.; Heck, S.; Marron, S.; Martinez-Alvarez, L.; Masarykova, D.; Mcmillan, P.; et al. Evaluation of skin laceration repair by tissue adhesive in the pediatric emergency room. Panminerva Med. 1992, 34, 77–80. [Google Scholar] [CrossRef]
  111. ADONI, A.; ANTEBY, E. The use of Histoacryl for episiotomy repair. Br. J. Obstet. Gynaecol. 1991, 98, 476–478. [Google Scholar] [CrossRef]
  112. Quinn, J.; Wells, G.; Sutcliffe, T.; Jarmuske, M.; Maw, J.; Stiell, L.; Johns, P. A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. J. Am. Med. Assoc. 1997, 277, 1527–1530. [Google Scholar] [CrossRef]
  113. Qureshi, A.; Drew, P.J.; Duthie, G.S.; Roberts, A.C.; Monson, J.R.T. n-Butyl cyanoacrylate adhesive for skin closure of abdominal wounds: Preliminary results. Ann. R. Coll. Surg. Engl. 1997, 79, 414. [Google Scholar]
  114. Kumar, P.; Venkatesh, V.; Chari, H. YashwanthYadav is tissue glue an alternative to sutures in impacted third molar surgeries? Indian J. Dent. Adv. 2017, 9, 8–14. [Google Scholar] [CrossRef]
  115. Farion, K.J.; Osmond, M.H.; Hartling, L.; Russell, K.F.; Klassen, T.P.; Crumley, E.; Wiebe, N. Tissue adhesives for traumatic lacerations: A systematic review of randomized controlled trials. Acad. Emerg. Med. 2003, 10, 110–118. [Google Scholar] [CrossRef]
  116. Wei, D.; Cai, J.; Yang, Y.; Zhao, T.; Zhang, H.; Zhang, C.; Zhang, Y.; Zhang, J.; Cai, F. A prospective comparison of short term results and functional recovery after laparoscopic subtotal colectomy and antiperistaltic cecorectal anastomosis with short colonic reservoir vs. long colonic reservoir. BMC Gastroenterol. 2015, 15, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Montanaro, L.; Arciola, C.R.; Cenni, E.; Ciapetti, G.; Savioli, F.; Filippini, F.; Barsanti, L.A. Cytotoxicity, blood compatibility and antimicrobial activity of two cyanoacrylate glues for surgical use. Biomaterials 2001, 22, 59–66. [Google Scholar] [CrossRef]
  118. Rushbrook, J.L.; White, G.; Kidger, L.; Marsh, P.; Taggart, T.F.O. The antibacterial effect of 2-octyl cyanoacrylate (Dermabond®) skin adhesive. J. Infect. Prev. 2014, 15, 236–239. [Google Scholar] [CrossRef] [Green Version]
  119. Abenavoli, F.M. Using Dermabond. Plast. Reconstr. Surg. 2001, 108, 269. [Google Scholar] [CrossRef]
  120. Bartenstein, D.W.; Cummins, D.L.; Rogers, G.S. A Prospective, Randomized, Single-Blind Study Comparing Cyanoacrylate Adhesives to Sutures for Wound Closure in Skin Cancer Patients. Dermatol. Surg. 2017, 43, 1371–1378. [Google Scholar] [CrossRef]
  121. Martines, G.; Picciariello, A.; Dibra, R.; Trigiante, G.; Jambrenghi, O.C.; Chetta, N.; Altomare, D.F. Efficacy of cyanoacrylate in the prevention of delayed bleeding after endoscopic mucosal resection of large colorectal polyps: A pilot study. Int. J. Colorectal Dis. 2020, 35, 2141–2144. [Google Scholar] [CrossRef]
  122. Toriumi, D.M.; O’Grady, K.; Desai, D.; Bagal, A. Use of octyl-2-cyanoacrylate for skin closure in facial plastic surgery. Plast. Reconstr. Surg. 1998, 102, 2209–2219. [Google Scholar] [CrossRef] [PubMed]
  123. Chan, Y.C.; Law, Y.; Cheung, G.C.; Ting, A.C.; Cheng, S.W. Cyanoacrylate glue used to treat great saphenous reflux: Measures of outcome. Phlebology 2017, 32, 99–106. [Google Scholar] [CrossRef] [PubMed]
  124. Dragu, A.; Unglaub, F.; Schwarz, S.; Beier, J.P.; Kneser, U.; Bach, A.D.; Horch, R.E. Foreign body reaction after usage of tissue adhesives for skin closure: A case report and review of the literature. Arch. Orthop. Trauma Surg. 2009, 129, 167–169. [Google Scholar] [CrossRef] [PubMed]
  125. Quinn, J.; Maw, J.; Ramotar, K.; Wenckebach, G.; Wells, G. Octylcyanoacrylate tissue adhesive versus suture wound repair in a contaminated wound model. Surgery 1997, 122, 69–72. [Google Scholar] [CrossRef]
  126. Zempsky, W.T.; Parrotti, D.; Grem, C.; Nichols, J. Randomized controlled comparison of cosmetic outcomes of simple facial lacerations closed with Steri Strip Skin Closures or Dermabond tissue adhesive. Pediatr. Emerg. Care 2004, 20, 519–524. [Google Scholar] [CrossRef]
  127. Bernard, L.; Doyle, J.; Friedlander, S.F.; Eichenfield, L.F.; Gibbs, N.F.; Cunningham, B.B. A prospective comparison of octyl cyanoacrylate tissue adhesive (dermabond) and suture for the closure of excisional wounds in children and adolescents. Arch. Dermatol. 2001, 137, 1177–1180. [Google Scholar] [CrossRef] [PubMed]
  128. Leggat, P.A.; Kedjarune, U.; Smith, D.R. Toxicity of Cyanoacrylate Adhesives and Their Occupational Impacts for Dental Staff. Ind. Health 2004, 42, 207–211. [Google Scholar] [CrossRef] [Green Version]
  129. Shantha, K.L.; Thennarasu, S.; Krishnamurti, N. Developments and applications of cyanoacrylate adhesives. J. Adhes. Sci. Technol. 2012, 3, 237–260. [Google Scholar] [CrossRef]
  130. Leggat, P.A.; Smith, D.R.; Kedjarune, U. Surgical applications of cyanoacrylate adhesives: A review of toxicity. ANZ J. Surg. 2007, 77, 209–213. [Google Scholar] [CrossRef]
  131. Wain, J.C.; Kaiser, L.R.; Johnstone, D.W.; Yang, S.C.; Wright, C.D.; Friedberg, J.S.; Feins, R.H.; Heitmiller, R.F.; Mathisen, D.J.; Selwyn, M.R. Trial of a novel synthetic sealant in preventing air leaks after lung resection. Ann. Thorac. Surg. 2001, 71, 1623–1629. [Google Scholar] [CrossRef]
  132. Bal-Ozturk, A.; Cecen, B.; Avci-Adali, M.; Topkaya, S.N.; Alarcin, E.; Yasayan, G.; Li, Y.C.E.; Bulkurcuoglu, B.; Akpek, A.; Avci, H.; et al. Tissue Adhesives: From Research to Clinical Translation. Nano Today 2021, 36, 101049. [Google Scholar] [CrossRef] [PubMed]
  133. Torchiana, D.F. Polyethylene glycol based synthetic sealants: Potential uses in cardiac surgery. J. Card. Surg. 2003, 18, 504–506. [Google Scholar] [CrossRef] [PubMed]
  134. Alleyne, C.H.; Cawley, C.M.; Barrow, D.L.; Poff, B.C.; Powell, M.D.; Sawhney, A.S.; Dillehay, D.L. Efficacy and biocompatibility of a photopolymerized, synthetic, absorbable hydrogel as a dural sealant in a canine craniotomy model. J. Neurosurg. 1998, 88, 308–313. [Google Scholar] [CrossRef]
  135. Slezak, P.; Klang, A.; Ferguson, J.; Monforte, X.; Schmidt, P.; Bauder, B.; Url, A.; Osuchowski, M.; Redl, H.; Spazierer, D.; et al. Tissue reactions to polyethylene glycol and glutaraldehyde-based surgical sealants in a rabbit aorta model. J. Biomater. Appl. 2020, 34, 1330–1340. [Google Scholar] [CrossRef] [Green Version]
  136. Glickman, M.; Gheissari, A.; Money, S.; Martin, J.; Ballard, J.L. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: Results of a randomized controlled trial. Arch. Surg. 2002, 137, 326–332. [Google Scholar] [CrossRef] [Green Version]
  137. Buskens, E.; Meijboom, M.J.; Kooijman, H.; Van Hout, B.A. The use of a surgical sealant (CoSeal®) in cardiac and vascular reconstructive surgery: An economic analysis. J. Cardiovasc. Surg. 2006, 47, 161–170. [Google Scholar]
  138. Lin, K.L.; Yang, D.Y.; Chu, I.M.; Cheng, F.C.; Chen, C.J.; Ho, S.P.; Pan, H.C. DuraSeal as a ligature in the anastomosis of rat sciatic nerve gap injury. J. Surg. Res. 2010, 161, 101–110. [Google Scholar] [CrossRef]
  139. Tjandra, J.J.; Chan, M.K.Y. A sprayable hydrogel adhesion barrier facilitates closure of defunctioning loop ileostomy: A randomized trial. Dis. Colon Rectum 2008, 51, 956–960. [Google Scholar] [CrossRef]
  140. Schnriger, B.; Barmparas, G.; Branco, B.C.; Lustenberger, T.; Inaba, K.; Demetriades, D. Prevention of postoperative peritoneal adhesions: A review of the literature. Am. J. Surg. 2011, 201, 111–121. [Google Scholar] [CrossRef]
  141. Tanaka, K.; Takamoto, S.; Ohtsuka, T.; Kotsuka, Y.; Kawauchi, M. Application of AdvaSeal for acute aortic dissection: Experimental study. Ann. Thorac. Surg. 1999, 68, 1308–1312. [Google Scholar] [CrossRef]
  142. Bhatia, S.K. Biomaterials for Clinical Applications; Springer: New York, NY, USA, 2010; pp. 1–283. [Google Scholar] [CrossRef]
  143. Giavaresi, G.; Tschon, M.; Borsari, V.; Daly, J.H.; Liggat, J.J.; Fini, M.; Bonazzi, V.; Nicolini, A.; Carpi, A.; Morra, M.; et al. New polymers for drug delivery systems in orthopaedics: In vivo biocompatibility evaluation. Biomed. Pharmacother. 2004, 58, 411–417. [Google Scholar] [CrossRef]
  144. Bezwada, R.S.; Jamiolkowski, D.D.; Lee, I.Y.; Agarwal, V.; Persivale, J.; Trenka-Benthin, S.; Erneta, M.; Suryadevara, J.; Yang, A.; Liu, S. Monocryl suture, a new ultra-pliable absorbable monofilament suture. Biomaterials 1995, 16, 1141–1148. [Google Scholar] [CrossRef]
  145. Sarasam, A.; Madihally, S.V. Characterization of chitosan–polycaprolactone blends for tissue engineering applications. Biomaterials 2005, 26, 5500–5508. [Google Scholar] [CrossRef]
  146. Ferreira, P.; Coelho, J.F.J.; Gil, M.H. Development of a new photocrosslinkable biodegradable bioadhesive. Int. J. Pharm. 2008, 352, 172–181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  147. Williams, C.G.; Malik, A.N.; Kim, T.K.; Manson, P.N.; Elisseeff, J.H. Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials 2005, 26, 1211–1218. [Google Scholar] [CrossRef] [PubMed]
  148. Ferreira, P.; Pereira, R.; Coelho, J.F.J.; Silva, A.F.M.; Gil, M.H. Modification of the biopolymer castor oil with free isocyanate groups to be applied as bioadhesive. Int. J. Biol. Macromol. 2007, 40, 144–152. [Google Scholar] [CrossRef] [Green Version]
  149. Heiss, C.; Kraus, R.; Schluckebier, D.; Stiller, A.C.; Wenisch, S.; Schnettler, R. Bone Adhesives in Trauma and Orthopedic Surgery. Eur. J. Trauma 2006, 32, 141–148. [Google Scholar] [CrossRef]
  150. Phaneuf, M.D.; Dempsey, D.J.; Bide, M.J.; Quist, W.C.; LoGerfo, F.W. Coating of Dacron vascular grafts with an ionic polyurethane: A novel sealant with protein binding properties. Biomaterials 2001, 22, 463–469. [Google Scholar] [CrossRef]
  151. Gilbert, T.W.; Badylak, S.F.; Gusenoff, J.; Beckman, E.J.; Clower, D.M.; Daly, P.; Rubin, J.P. Lysine-derived urethane surgical adhesive prevents seroma formation in a canine abdominoplasty model. Plast. Reconstr. Surg. 2008, 122, 95–102. [Google Scholar] [CrossRef]
  152. TissuGlu® Surgical Adhesive Patient Information Brochure; Cohera Medical, Inc.: Oplotnica, Slovenia, 2014.
  153. Stewart, R.J.; Wang, C.S.; Shao, H. Complex coacervates as a foundation for synthetic underwater adhesives. Adv. Colloid Interface Sci. 2011, 167, 85–93. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  154. Waite, J.H. Nature’s underwater adhesive specialist. Int. J. Adhes. Adhes. 1987, 7, 9–14. [Google Scholar] [CrossRef]
  155. Seo, S.; Lee, D.W.; Ahn, J.S.; Cunha, K.; Filippidi, E.; Ju, S.W.; Shin, E.; Kim, B.S.; Levine, Z.A.; Lins, R.D.; et al. Significant Performance Enhancement of Polymer Resins by Bioinspired Dynamic Bonding. Adv. Mater. 2017, 29, 1703026. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  156. Priemel, T.; Degtyar, E.; Dean, M.N.; Harrington, M.J. Rapid self-assembly of complex biomolecular architectures during mussel byssus biofabrication. Nat. Commun. 2017, 8, 14539. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  157. Lee, B.P.; Messersmith, P.B.; Israelachvili, J.N.; Waite, J.H. Mussel-Inspired Adhesives and Coatings. Annu. Rev. Mater. Sci. 2011, 41, 99–132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  158. Rahimnejad, M.; Zhong, W. Mussel-inspired hydrogel tissue adhesives for wound closure. RSC Adv. 2017, 7, 47380–47396. [Google Scholar] [CrossRef] [Green Version]
  159. Dove, J.; Sheridan, P. Adhesive protein from mussels: Possibilities for dentistry, medicine, and industry. J. Am. Dent. Assoc. 1986, 112, 879. [Google Scholar] [CrossRef]
  160. Grande, D.; Pitman, M. The use of adhesives in chondrocyte transplantation surgery. Preliminary studies. Bull. Hosp. Jt. Dis. Orthop. Inst. 1988, 48, 140–148. [Google Scholar]
  161. Waite, J.H. Adhesion à la Moule. Integr. Comp. Biol. 2002, 42, 1172–1180. [Google Scholar] [CrossRef]
  162. Qin, X.X.; Coyne, K.J.; Waite, J.H. Tough tendons. Mussel byssus has collagen with silk-like domains. J. Biol. Chem. 1997, 272, 32623–32627. [Google Scholar] [CrossRef] [Green Version]
  163. Waite, J.H. Evidence for a repeating 3,4-dihydroxyphenylalanine- and hydroxyproline-containing decapeptide in the adhesive protein of the mussel, Mytilus edulis L. J. Biol. Chem. 1983, 258, 2911–2915. [Google Scholar] [CrossRef]
  164. Waite, J.H.; Tanzer, M.L. Polyphenolic Substance of Mytilus edulis: Novel Adhesive Containing L-Dopa and Hydroxyproline. Science 1981, 212, 1038–1040. [Google Scholar] [CrossRef] [PubMed]
  165. Two Firms Race to Derive Profits from Mussels’ Glue. Available online: https://www.the-scientist.com/news/two-firms-race-to-derive-profits-from-mussels-glue-61325 (accessed on 13 February 2022).
  166. Pennisi, E. Geckos Climb by the Hairs of Their Toes. Science 2000, 288, 1717–1718. [Google Scholar] [CrossRef]
  167. Autumn, K.; Liang, Y.A.; Hsieh, S.T.; Zesch, W.; Chan, W.P.; Kenny, T.W.; Fearing, R.; Full, R.J. Adhesive force of a single gecko foot-hair. Nature 2000, 405, 681–685. [Google Scholar] [CrossRef]
  168. Autumn, K.; Sitti, M.; Liang, Y.A.; Peattie, A.M.; Hansen, W.R.; Sponberg, S.; Kenny, T.W.; Fearing, R.; Israelachvili, J.N.; Full, R.J. Evidence for van der Waals adhesion in gecko setae. Proc. Natl. Acad. Sci. USA 2002, 99, 12252–12256. [Google Scholar] [CrossRef] [Green Version]
  169. Lee, H.; Lee, B.P.; Messersmith, P.B. A reversible wet/dry adhesive inspired by mussels and geckos. Nature 2007, 448, 338–341. [Google Scholar] [CrossRef]
  170. Mahdavi, A.; Ferreira, L.; Sundback, C.; Nichol, J.W.; Chan, E.P.; Carter, D.J.D.; Bettinger, C.J.; Patanavanich, S.; Chignozha, L.; Ben-Joseph, E.; et al. A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc. Natl. Acad. Sci. USA 2008, 105, 2307–2312. [Google Scholar] [CrossRef] [Green Version]
  171. Li, J.; Celiz, A.D.; Yang, J.; Yang, Q.; Wamala, I.; Whyte, W.; Seo, B.R.; Vasilyev, N.V.; Vlassak, J.J.; Suo, Z.; et al. Tough adhesives for diverse wet surfaces. Science 2017, 357, 378–381. [Google Scholar] [CrossRef] [Green Version]
  172. Xu, K.; Liu, Y.; Bu, S.; Wu, T.; Chang, Q.; Singh, G.; Cao, X.; Deng, C.; Li, B.; Luo, G.; et al. Egg Albumen as a Fast and Strong Medical Adhesive Glue. Adv. Healthc. Mater. 2017, 6, 1700132. [Google Scholar] [CrossRef] [PubMed]
  173. Zakrzewski, W.; Dobrzyński, M.; Szymonowicz, M.; Rybak, Z. Stem cells: Past, present, and future. Stem Cell Res. Ther. 2019, 10, 68. [Google Scholar] [CrossRef]
  174. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 2007, 131, 861–872. [Google Scholar] [CrossRef] [Green Version]
  175. Wu, X.; Ren, J.; Li, J. Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine. Cytotherapy 2012, 14, 555–562. [Google Scholar] [CrossRef]
  176. Porada, C.; Zanjani, E.; Almeida-Porada, G. Adult mesenchymal stem cells: A pluripotent population with multiple applications. Curr. Stem Cell Res. Ther. 2006, 1, 365–369. [Google Scholar] [CrossRef]
  177. Ortiz, A.D.C.; Fideles, S.O.M.; Pomini, K.T.; Reis, C.H.B.; Bueno, C.R.D.S.; Pereira, E.D.S.B.M.; Rossi, J.D.O.; Novais, P.C.; Pilon, J.P.G.; Junior, G.M.R.; et al. Effects of Therapy with Fibrin Glue combined with Mesenchymal Stem Cells (MSCs) on Bone Regeneration: A Systematic Review. Cells 2021, 10, 2323. [Google Scholar] [CrossRef]
  178. Murphy, M.B.; Moncivais, K.; Caplan, A.I. Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 2013, 45, e54. [Google Scholar] [CrossRef] [Green Version]
  179. Zakrzewski, W.; Dobrzynski, M.; Wiglusz, R.J.; Rybak, Z.; Szymonowicz, M. Selected Nanomaterials’ Application Enhanced with the Use of Stem Cells in Acceleration of Alveolar Bone Regeneration during Augmentation Process. Nanomaterials 2020, 10, 1216. [Google Scholar] [CrossRef]
  180. Cherubino, M.; Rubin, J.P.; Miljkovic, N.; Kelmendi-Doko, A.; Marra, K.G. Adipose-derived stem cells for wound healing applications. Ann. Plast. Surg. 2011, 66, 210–215. [Google Scholar] [CrossRef]
  181. Wu, Y.; Chen, L.; Scott, P.G.; Tredget, E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25, 2648–2659. [Google Scholar] [CrossRef] [Green Version]
  182. Branski, L.K.; Gauglitz, G.G.; Herndon, D.N.; Jeschke, M.G. A review of gene and stem cell therapy in cutaneous wound healing. Burns 2009, 35, 171–180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  183. Ebrahimian, T.G.; Pouzoulet, F.; Squiban, C.; Buard, V.; André, M.; Cousin, B.; Gourmelon, P.; Benderitter, M.; Casteilla, L.; Tamarat, R. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 503–510. [Google Scholar] [CrossRef] [Green Version]
  184. Kim, W.S.; Park, B.S.; Sung, J.H.; Yang, J.M.; Park, S.B.; Kwak, S.J.; Park, J.S. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. J. Dermatol. Sci. 2007, 48, 15–24. [Google Scholar] [CrossRef]
  185. Gao, X.; Cheng, H.; Sun, X.; Lu, A.; Ruzbarsky, J.J.; Wang, B.; Huard, J. Comparison of autologous blood clots with fibrin sealant as scaffolds for promoting human muscle-derived stem cell-mediated bone regeneration. Biomedicines 2021, 9, 983. [Google Scholar] [CrossRef]
  186. Krug, C.; Beer, A.; Hartmann, B.; Prein, C.; Clause-Schaumann, H.; Holzbach, T.; Aszodi, A.; Giunta, R.E.; Saller, M.M.; Volkmer, E. Fibrin glue displays promising in vitro characteristics as a potential carrier of adipose progenitor cells for tissue regeneration. J. Tissue Eng. Regen. Med. 2019, 13, 359–368. [Google Scholar] [CrossRef]
  187. Ahmed, T.A.E.; Dare, E.V.; Hincke, M. Fibrin: A Versatile Scaffold for Tissue Engineering Applications. Tissue Eng. Part B Rev. 2008, 14, 199–215. [Google Scholar] [CrossRef]
  188. De la Puente, P.; Ludeña, D. Cell culture in autologous fibrin scaffolds for applications in tissue engineering. Exp. Cell Res. 2014, 322, 1–11. [Google Scholar] [CrossRef] [PubMed]
  189. Yoo, W.J.; Choi, I.H.; Chung, C.Y.; Cho, T.J.; Kim, I.O.; Kim, C.J. Implantation of perichondrium-derived chondrocytes in physeal defects of rabbit tibiae. Acta Orthop. 2005, 76, 628–636. [Google Scholar] [CrossRef] [Green Version]
  190. Ito, K.; Yamada, Y.; Naiki, T.; Ueda, M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin. Oral Implants Res. 2006, 17, 579–586. [Google Scholar] [CrossRef]
  191. Lee, M.G.M.; Jones, D. Applications of fibrin sealant in surgery. Surg. Innov. 2005, 12, 203–213. [Google Scholar] [CrossRef]
  192. Sanders, L.; Nagatomi, J. Clinical Applications of Surgical Adhesives and Sealants. Crit. Rev. Biomed. Eng. 2014, 42, 271. [Google Scholar] [CrossRef]
  193. Spotnitz, W.D.; Burks, S. Hemostats, sealants, and adhesives III: A new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion 2012, 52, 2243–2255. [Google Scholar] [CrossRef]
  194. Duarte, A.P.; Coelho, J.F.; Bordado, J.C.; Cidade, M.T.; Gil, M.H. Surgical adhesives: Systematic review of the main types and development forecast. Prog. Polym. Sci. 2012, 37, 1031–1050. [Google Scholar] [CrossRef]
  195. Andreotti Damante, C.; Cardoso, M.V.; Hage Karam, P.S.B.; Haiter, A.C.; Sant’Ana, A.C.P.; Greghi, S.L.A.; Zangrando, M.S.R.; De Rezende, M.L.R.; Oliveira, R.C. Evaluation of Regular Market Ethyl Cyanoacrylate Cytotoxicity for Human Gingival Fibroblasts and Osteoblasts. Surg. Infect. 2020, 21, 29–34. [Google Scholar] [CrossRef] [PubMed]
  196. Perrin, B.R.M.; Dupeux, M.; Tozzi, P.; Delay, D.; Gersbach, P.; von Segesser, L.K. Surgical glues: Are they really adhesive? Eur. J. Cardio-Thoracic Surg. 2009, 36, 967–972. [Google Scholar] [CrossRef]
  197. Black, K. Tissue Restoration and Repair—Application of Cutting-edge Technologies to Surgical Procedures. In Business Briefing: Medical Device Manufacturing and Technology; Cooper, E., Ed.; Business Briefings Ltd.: London, UK, 2002; pp. 1–3. [Google Scholar]
  198. Ahn, B.K. Perspectives on Mussel-Inspired Wet Adhesion. J. Am. Chem. Soc. 2017, 139, 10166–10171. [Google Scholar] [CrossRef] [Green Version]
Table 1. Types of medical adhesives and their potential application in medicine.
Table 1. Types of medical adhesives and their potential application in medicine.
Type of GlueApplicationReferences
(1) Natural adhesives
(1a) Fibrin adhesivehemostasis during cardiac surgery; sealing of vascular grafts; support in the treatment of aortic dissection in vascular surgery; prevention of cerebrospinal fluid leakage during neurosurgery; hemostasis control in bleeding from burn wounds; in endoscopy for the treatment of bleeding from peptic ulcers implantation of biomaterials in inguinal hernia operations; treatment of lymphangiomas; treatment of lymphocele; prevention of lymphatic leakage; use of adhesive for pleurodesis; in thoracic surgery for treatment of bronchial fistulas; for pleural sealing; treatment of damaged nerves; reduction of bleeding in orthopedic surgery [21,22,23,24,31,32,33,34,35,36,38,39,40,41,42,43,44,45]
(1b) Collagen adhesivefor controlling hemostasis in vascular surgery; the prevention and treatment of cerebrospinal fluid leaks in neurosurgery; the endoscopic treatment of gastrointestinal bleeding[58,63]
(1c) Gelatin adhesivecardiac and vascular surgery to produce hemostasis and stop bleeding from vessels; control hemostasis in vascular and organ bleeding in general surgical procedures [73,75,197]
(1d) Chitosan-based adhesivestaunching of organ and venous bleeding; treatment of damaged nerves, intestines, and closure of skin wounds; treatment of scleral injuries; maintenance of hemostasis after endovascular interventions[77,78,79,80,82,83,84,85,86]
(1e) Chondroitin-based adhesiveorthopedics for implantation of biomaterials; in ophthalmology as an alternative to sutures[91,93,94]
(2) Synthetic adhesives
(2a) Cyanoacrylate-based adhesiveendoscopic treatment of gastrointestinal bleeding; treatment of acute arterial hemorrhage; implantation of biomaterials during inguinal hernia surgery; support of tissue healing during dental implant surgery; treatment of hypersensitivity after dental procedures; closure of skin wounds and mucous membranes; treatment of venous insufficiency of the lower limbs; use for neurological embolization[104,105,106,107,108,109,110,111,112,113,114]
(2b) Polyethylene glycol (PEG)-based adhesiveprevention of suture line leakage in thoracic surgery and cerebrospinal fluid leakage after neurosurgery; prevention of anastomotic leakage in vascular and cardiac surgery; wound closure and sealing in general surgery, gynecology, and ophthalmology; nerve regeneration.[131,133,134,136,137,138,139,140]
(2c) Urethane-based adhesive soft tissue fusion in general, and plastic surgery and orthopedics; sealing of vascular prostheses in angiosurgical procedures.[72,143,144,145,148]
(3) Biomimetic adhesives
(3a) Adhesive based on mussel adhesion proteinspotential applications in cell and tissue interfacing[160,161,162,198]
(3b) Adhesive based on the adhesive properties of the gecko sealing anastomoses; controlling bleeding from wounds, burns, and ulcers; implantation of biomaterials[170]
(3c) Adhesive based on snail mucuscontrol of arterial and parenchymal hemorrhages; skin wound closure; biomaterial implantation[171]
(3d) Adhesive based on chicken egg whiteskin wound closure[172]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mazur, M.; Zakrzewski, W.; Szymonowicz, M.; Rybak, Z. Medical Adhesives and Their Role in Laparoscopic Surgery—A Review of Literature. Materials 2022, 15, 5215. https://doi.org/10.3390/ma15155215

AMA Style

Mazur M, Zakrzewski W, Szymonowicz M, Rybak Z. Medical Adhesives and Their Role in Laparoscopic Surgery—A Review of Literature. Materials. 2022; 15(15):5215. https://doi.org/10.3390/ma15155215

Chicago/Turabian Style

Mazur, Maciej, Wojciech Zakrzewski, Maria Szymonowicz, and Zbigniew Rybak. 2022. "Medical Adhesives and Their Role in Laparoscopic Surgery—A Review of Literature" Materials 15, no. 15: 5215. https://doi.org/10.3390/ma15155215

APA Style

Mazur, M., Zakrzewski, W., Szymonowicz, M., & Rybak, Z. (2022). Medical Adhesives and Their Role in Laparoscopic Surgery—A Review of Literature. Materials, 15(15), 5215. https://doi.org/10.3390/ma15155215

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop